Kendall Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.05M Sell
2,996
-1
-0% -$356 0.22% 115
2025
Q4
$981K Sell
2,997
-20
-0.7% -$6.34K 0.21% 118
2025
Q3
$851K Sell
3,017
-90
-3% -$26.1K 0.19% 120
2025
Q2
$868K Buy
3,107
+32
+1% +$9.06K 0.23% 111
2025
Q1
$958K Sell
3,075
-15
-0.5% -$4.43K 0.28% 97
2024
Q4
$805K Sell
3,090
-850
-22% -$252K 0.24% 109
2024
Q3
$1.27M Sell
3,940
-170
-4% -$55.6K 0.39% 77
2024
Q2
$1.28M Sell
4,110
-416
-9% -$122K 0.43% 69
2024
Q1
$1.29M Sell
4,526
-95
-2% -$27.8K 0.44% 73
2023
Q4
$1.33M Sell
4,621
-170
-4% -$46.3K 0.52% 61
2023
Q3
$1.29M Sell
4,791
-30
-0.6% -$7.49K 0.57% 58
2023
Q2
$1.07M Buy
4,821
+350
+8% +$81.2K 0.47% 74
2023
Q1
$1.08M Sell
4,471
-33
-0.7% -$8.1K 0.52% 63
2022
Q4
$1.18M Sell
4,504
-60
-1% -$16.1K 0.6% 53
2022
Q3
$1.03M Sell
4,564
-25
-0.5% -$6.06K 0.6% 54
2022
Q2
$1.12M Sell
4,589
-75
-2% -$18.4K 0.62% 50
2022
Q1
$1.13M Buy
4,664
+140
+3% +$32.2K 0.55% 59
2021
Q4
$1.02M Hold
4,524
0.48% 70
2021
Q3
$962K Buy
4,524
+9
+0.2% +$2.07K 0.52% 63
2021
Q2
$1.1M Buy
4,515
+190
+4% +$46.7K 0.62% 54
2021
Q1
$1.08M Hold
4,325
0.67% 51
2020
Q4
$994K Sell
4,325
-170
-4% -$39.2K 0.73% 47
2020
Q3
$1.14M Sell
4,495
-1,175
-21% -$291K 0.99% 37
2020
Q2
$1.34M Sell
5,670
-363
-6% -$82.8K 1.28% 28
2020
Q1
$1.22M Sell
6,033
-1,355
-18% -$296K 1.38% 21
2019
Q4
$1.78M Buy
7,388
+55
+0.8% +$12.1K 1.4% 18
2019
Q3
$1.42M Sell
7,333
-205
-3% -$39.3K 1.25% 22
2019
Q2
$1.39M Sell
7,538
-195
-3% -$34.9K 1.26% 21
2019
Q1
$1.47M Sell
7,733
-90
-1% -$17.2K 1.39% 19
2018
Q4
$1.52M Buy
7,823
+220
+3% +$42.9K 1.58% 16
2018
Q3
$1.58M Sell
7,603
-140
-2% -$27.6K 1.34% 21
2018
Q2
$1.43M Sell
7,743
-26
-0.3% -$4.6K 1.26% 22
2018
Q1
$1.32M Buy
7,769
+60
+0.8% +$11K 1.15% 23
2017
Q4
$1.34M Buy
+7,709
New +$1.36M 1.19% 23

Other funds holding AMGN

Kendall Capital Management's AMGN Position: Q1 2026 in Review

Kendall Capital Management reduced its Amgen (AMGN) stake by 0.03% in Q1 2026, selling an estimated $356 and leaving 2,996 shares worth $1.05M. The position accounts for 0.22% of the portfolio, ranked #115.

Kendall Capital Management first reported a position in AMGN in Q4 2017 and has held it in 34 quarters since. The position peaked at $1.78M in Q4 2019. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Kendall Capital Management held 2,996 shares of Amgen worth $1.05M as of Q1 2026.
  • Kendall Capital Management sold 1 Amgen share in Q1 2026, an estimated $356.
  • Amgen made up 0.22% of Kendall Capital Management's portfolio in Q1 2026, its #115 holding.
  • Kendall Capital Management first reported a position in Amgen in Q4 2017 and has held it in 34 quarters since.
  • Kendall Capital Management's Amgen position peaked at $1.78M in Q4 2019.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Kendall Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.